Yearly Archives: 2007

Statement from the American Association of Clinical Endocrinologists regarding The New England Journal of Medicine article, "Effect of Rosiglitazone (Avandia) on the Risk of Myocardial Infarction and Death from Cardiovascular Causes."

The FDA is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.

New research suggests that for those who have been successful at losing weight, reducing calories is an effective way to keep weight off, especially when it is difficult to find time to exercise.

Spending money to improve diabetes care at federally qualified community health centers is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care.

A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.

The study found that regardless of whether clogged coronary arteries were propped open with a drug-eluting or bare metal stent, diabetic patients were more likely to enjoy continued good health if treatment was continued for more than 6 months.

Higher dietary intake of fiber from grains and cereals and of magnesium may each be associated with a lower risk of type 2 diabetes, according to a report.

Employees who participated in a worksite health program improved blood pressure control by 9 percent and diabetes control by 15 percent, researchers reported.

Diabetes researchers, investigating how the body supplies itself with insulin, discovered to their surprise that adult stem cells, which they expected to play a crucial role in the process, were nowhere to be found.

A Mediterranean diet halves the chances of developing progressive inflammatory lung disease (COPD), reveals a large study.

Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury.

Overweight individuals who secrete insulin at a higher level may experience greater weight loss by selecting a low-glycemic load diet, compared to a low-fat diet, according to a study.

For young patients with the kidney disease IgA nephropathy (IgAN), early treatment with angiotensin-converting enzyme (ACE) inhibitors can reduce the long-term risk of irreversible kidney damage.

Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension.

Researchers have found that patients with obstructive sleep apnea are at increased risk for developing of type 2 diabetes, independent of other risk factors.

After screening hundreds of compounds for their effects on fat development, researchers have discovered that an ingredient found in some plants fights diabetes without some of the side effects attributed to other antidiabetes drugs.